Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
Clinical trial NCT03126864 · TERMINATED
Trial details
- NCT number
- NCT03126864
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-04
- Primary completion
- 2019-10-10
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.